NETANYA, Israel (June 12, 2019)—Eitan Group, a provider of advanced infusion therapy solutions across the care continuum, announced the appointment of Chris Lowery to its board of directors.
Lowery is a medical device and supplies industry veteran with more than 25 years of health care experience. He is currently the President of Owens & Minor’s global products business unit, which last year acquired Halyard Health’s Surgical & Infection Prevention (S&IP) Business for $710 million. His prior roles include Chief Operating Officer of Halyard Health, Vice President of Global Healthcare Sales and Marketing at Kimberly Clark Healthcare and Vice President and Global General Manager at Covidien.
“Eitan Group is a burgeoning leader in infusion therapy solutions, steering innovation with its advanced and intuitive systems that meet the current and future demands of health care providers and patients,” said Chris Lowery. “The company is meeting the evolving needs of the infusion market, with a team of over 100 engineers ensuring that its flagship Sapphire infusion system, as well as the Avoset pump are easy, safe and cost effective to use. This level of innovation is what drew me to join Eitan Group at this exciting time of growth and expansion.”
“Chris’s broad background, ranging from his days as an officer in the U.S. Navy to his various leadership roles in large medical device companies, gives him a wide lens on the health care industry. His vision and guidance will be invaluable to Eitan Group as we navigate our rapid growth in the U.S.,” said Roger Massengale, CEO of Eitan Group North America. “He brings the perfect balance of technical knowledge, industry experience and business savvy to Eitan Group, in addition to his proven track record of improving profitability. His counsel will be vital as we begin our direct sales to our North American customers.”
Eitan Group companies Sapphire Medical, Avoset Health and Sorrel Medical offer infusion therapy solutions to meet patient and provider needs across the continuum of care. Sapphire provides its robust system to the hospital and homecare markets; Avoset Health will provide dedicated infusion solutions for the homecare market; and Sorrel Medical offers pharma partners a flexible wearable platform for the safe self-administration of new biologic drugs.
Visit eitan.group for more information.
